Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Dry Eye Disease Chamber Crossover Clinical Trial of Reproxalap  https://t.co/yRIGIcKTrq  https://t.co/q9k7gHoXY5